Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration

被引:39
|
作者
Yadav, Dawesh P. [1 ]
Kedia, Saurabh [1 ]
Madhusudhan, Kumble Seetharama [2 ]
Bopanna, Sawan [1 ]
Goyal, Sandeep [1 ]
Jain, Saransh [1 ]
Vikram, Naval K. [3 ]
Sharma, Raju [2 ]
Makharia, Govind K. [1 ]
Ahuja, Vineet [1 ]
机构
[1] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Radiodiagnosis, New Delhi 110029, India
[3] All India Inst Med Sci, Dept Med, New Delhi 110029, India
关键词
INFLAMMATORY-BOWEL-DISEASE; VISCERAL FAT AREA; CHILDREN; ADIPOSITY; ADULTS; INDEX; RATIO; RISK; MASS;
D O I
10.1155/2017/1215035
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Results on body composition in Crohn's disease (CD) and ulcerative colitis (UC) have been heterogeneous and are lacking from Asia. Present study assessed body composition in CD/UC and correlated it with disease severity/duration. Methods. Patients of CD/UC following between Dec 2014 and Dec 2015 who consented for bioimpedance analysis for body fat measurement were included. Lean mass and fat-free mass index (FFMI) were calculated with standard formulae. Visceral fat area (VFA), subcutaneous fat area (SCA), and visceral to subcutaneous fat ratio (VF/SC) were evaluated in CD patients on abdominal CT. Results. Lean mass in CD (n = 44, mean age: 41.2 +/- 15.8 years, 73% males) was significantly lower than UC (n = 53, mean age: 33.2 +/- 11.2 years, 68% males; 44.2 +/- 7.8 versus 48.3 +/- 8.4 Kg, p = 0.01). In both UC/CD, disease severity was associated with nonsignificant decline in BMI (UC: 22.1 +/- 4.9 versus 20.2 +/- 3.2 versus 19.9 +/- 3.2 kg/m(2), p = 0.23; CD: 22.1 +/- 4.2 versus 19.9 +/- 2.3 versus 19.7 +/- 4.2 kg/m(2), p = 0.18) and fat mass (UC: 10.9 +/- 8.9 versus 8.1 +/- 5.9 versus 5.7 +/- 3.6 kg, p = 0.14; CD: 11.2 +/- 7 versus 7.9 +/- 4.4 versus 7.2 +/- 5.9 kg, p = 0.16), and disease duration was associated with significant decline in FFMI (p < 0.05). In CD, disease severity was associated with nonsignificant decline in SCA and increase in VF/SC. Conclusions. CD patients have lower lean mass than UC. Body fat decreases with increasing disease severity and fat-free mass decreases with increasing disease duration in both UC/CD.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Differential therapy of ulcerative colitis and Crohn's disease
    Stange, EF
    LEBER MAGEN DARM, 1999, 29 (05) : 221 - 226
  • [32] The role of filgotinib in ulcerative colitis and Crohn's disease
    Fanizza, Jacopo
    D'Amico, Ferdinando
    Lauri, Gaetano
    Martinez-Dominguez, Samuel J.
    Allocca, Mariangela
    Furfaro, Federica
    Zilli, Alessandra
    Fiorino, Gionata
    Parigi, Tommaso Lorenzo
    Radice, Simona
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    IMMUNOTHERAPY, 2024, 16 (02) : 59 - 74
  • [33] Psychopathological aspects in Crohn's disease and ulcerative colitis
    Tobon, Sergio
    Vinaccia, Stefano
    Margarita Quiceno, Japcy
    Sandin, Bonifacio
    Nunez Rojas, Ariel Cesar
    AVANCES EN PSICOLOGIA LATINOAMERICANA, 2007, 25 (02): : 83 - 97
  • [34] Crohn's disease and ulcerative colitis in the same family
    Maté-Jiménez, J
    Ekbom, A
    Pajares-García, JM
    López-Nava, G
    Sandborn, WJ
    Gomollón, F
    DRUGS OF TODAY, 2001, 37 : 229 - 230
  • [35] The differential diagnosis of Crohn's disease and ulcerative colitis
    Sanders, DSA
    BAILLIERES CLINICAL GASTROENTEROLOGY, 1998, 12 (01): : 19 - 33
  • [36] Crohn's disease and ulcerative colitis: Antibodies and men
    Duclos, B
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1995, 19 (11): : 865 - 866
  • [37] The Genetics Universe of Crohn's Disease and Ulcerative Colitis
    Parkes, Miles
    DIGESTIVE DISEASES, 2012, 30 : 78 - 81
  • [38] Prevalence of ulcerative colitis and Crohn's disease in Japan
    Asakura, Keiko
    Nishiwaki, Yuji
    Inoue, Nagamu
    Hibi, Toshifumi
    Watanabe, Mamoru
    Takebayashi, Toru
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 659 - 665
  • [39] Ulcerative colitis or Crohn's disease? Pitfalls and problems
    Feakins, Roger M.
    HISTOPATHOLOGY, 2014, 64 (03) : 317 - 335
  • [40] Aminosalicylates in the treatment of ulcerative colitis and Crohn's disease
    Sutherland, LR
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 201 - 209